A comprehensive approach to the prevention of bronchopulmonary dysplasia

@article{Kugelman2011ACA,
  title={A comprehensive approach to the prevention of bronchopulmonary dysplasia},
  author={A. Kugelman and M. Durand},
  journal={Pediatric Pulmonology},
  year={2011},
  volume={46}
}
The current bronchopulmonary dysplasia (BPD) is seen in infants born extremely premature, with less severe respiratory distress syndrome (RDS) and who received prenatal steroids—“new BPD”. The pathophysiology of BPD is based on an impairment of lung maturation with prenatal and postnatal multi‐hit insults and genetic susceptibility. This multifactorial pathophysiology of BPD suggests that no single “magic bullet” will prevent it. Thus, to avoid BPD we need to implement a complex and… Expand
Advances in bronchopulmonary dysplasia
TLDR
Current and potential future therapeutic strategies for Bronchopulmonary dysplasia are reviewed and stem cell-based therapies are a new investigational strategy showing promise for the prevention or treatment of BPD. Expand
Nutrition and bronchopulmonary dysplasia
  • C. Dani, C. Poggi
  • Medicine
  • The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
  • 2012
TLDR
Early nutrition support and careful adjustment of parenteral nutrition and appropriate enteral feeding selection may enhance the growth and contribute a better neurodevelopment in patients with bronchopulmonary dysplasia or BPD. Expand
The potential of non-invasive ventilation to decrease BPD.
TLDR
The progress made in the last 5 years in the use of nasal continuous positive airways pressure (NCPAP) and nasal intermittent positive pressure ventilation (NIPPV) as it pertains to impacting on BPD rates is reviewed. Expand
Bronchopulmonary Dysplasia in Premature Infants with Very Low Birth Weight: A Single Centre Retrospective Study in China
TLDR
It is suggested that low GA was the most important risk factor for BPD, DEX reduced oxygen dependency but decreased weight gain, and the oxygen requirement had significantly reduced compared to the week prior to treatment. Expand
Bronchopulmonary Dysplasia: Structural Challenges and Stem Cell Treatment Potential
  • D. Niver
  • Medicine
  • Advances in neonatal care : official journal of the National Association of Neonatal Nurses
  • 2014
TLDR
The findings of several mesenchymal stem cell experiments are reviewed and the potential for future treatment to help repair the lungs in infants with BPD is reviewed. Expand
Future treatment for BPD
TLDR
Targeting a treatment that will help repair the lungs, restore architecture, and promote lung development for infants who are developing chronic lung disease is exactly what is necessary. Expand
Minimizing the risk of respiratory distress syndrome
TLDR
The use of antenatal steroids and pulmonary surfactant have revolutionized perinatal medicine, however a number of controversies still exist for both treatments such as optimal dosing, timing, and repeat courses. Expand
Prevention and treatment of chronic lung disease
The increased survival among very low birth weight (VLBW) contributes to the overall increase in the incidence of chronic lung disease (CLD), also known as bronchopulmonary dysplasia (BPD), thatExpand
News on neonatal respiratory research
TLDR
The role of the sustained lung inflation procedure in the delivery room, the development of new exogenous surfactant preparations, the effectiveness of nasal high frequency ventilation (nHFV), and the treatment of patent ductusarteriosus with paracetamol are reported on. Expand
Optimization of Airway Medications in the Infant
TLDR
The most prominent airway medication, surfactant for respiratory distress syndrome, will be discussed elsewhere in this issue of Neonatology, and indications such as the prevention of bronchopulmonary dysplasia are the focus of a large multicenter international trial. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 132 REFERENCES
Emerging drugs for the prevention of bronchopulmonary dysplasia.
TLDR
Systemically administered corticosteroids, if given in the first 2 weeks, do significantly reduce BPD but have serious side effects, and further investigation is needed to identify the safest dosage regimen. Expand
Pulmonary function outcomes in bronchopulmonary dysplasia through childhood and into adulthood: implications for primary care.
TLDR
The pulmonary function outcomes resulting from BPD through later childhood and young adulthood are reviewed, which has been coined the 'new' BPD. Expand
Postnatal Corticosteroids to Prevent or Treat Bronchopulmonary Dysplasia
TLDR
High-dose dexamethasone (0.5 mg/kg per day) does not seem to confer additional therapeutic benefit over lower doses and is not recommended, and evidence is insufficient to make a recommendation regarding other glucocorticoid doses and preparations. Expand
Antenatal factors and the development of bronchopulmonary dysplasia.
  • A. Jobe
  • Medicine
  • Seminars in neonatology : SN
  • 2003
TLDR
The hypothesis developed is that bronchopulmonary dysplasia occurs because of repetitive adverse lung exposures, or hits, and that the initial hits may be antenatal glucocorticoid exposure and/or antenatal inflammation. Expand
Inhaled drugs for the prevention and treatment of bronchopulmonary dysplasia
Bronchopulmonary dysplasia (BPD) is one of the most common long‐term complications and treatment challenges in preterm infants. Theoretically, inhaled corticosteroids may suppress pulmonaryExpand
Postnatal corticosteroids for bronchopulmonary dysplasia.
  • A. Jobe
  • Medicine
  • Clinics in perinatology
  • 2009
TLDR
An approach to minimizing risk is to use low-dose, short-duration treatments in the highest risk ventilator-dependent patients to improve lung function in infants who are progressing toward bronchopulmonary dysplasia. Expand
Bronchopulmonary dysplasia – prevalence, severity and predictive factors in a national cohort of extremely premature infants
Aim:  To study prevalence and predictive factors of bronchopulmonary dysplasia (BPD) in a cohort of preterm infants with a high incidence of prenatal steroid and surfactant treatment.
[Bronchopulmonary dysplasia].
TLDR
A wide-ranging review of the literature on bronchopulmonary dysplasia is presented, covering new definitions, pathophysiology, prevention, treatment, prognosis and progression. Expand
Does bronchopulmonary dysplasia contribute to the occurrence of cerebral palsy among infants born before 28 weeks of gestation?
TLDR
Combined treatment with both MV and supplemental oxygen at 36 weeks PMA strongly predicts the more common bilateral CP phenotypes, and BPD without MV at 36 Weeks PMA was not significantly associated with any form of CP. Expand
The role of nutrition in the prevention and management of bronchopulmonary dysplasia.
TLDR
Close post discharge follow up of infants with BPD is necessary to monitor growth and to ensure intake of sufficient protein and calories. Expand
...
1
2
3
4
5
...